Day: Biotech
News
Plectonic Biotech receives Sprind funding
The Federal Agency for Disruptive Innovations – Sprind for short – will finance the work of the TUM spin-off Plectonic Biotech in the coming years.…
News
Catalym secures 50 million euros
Catalym raises €50 million in a Series C round. The Martinsried-based biotech startup plans to use the newly raised capital…
Podcast
Cutting-edge research meets application: Biotech from Munich
With the Innovation and Start-up Center for Biotechnology (IZB) and numerous startups in the industry, Munich is considered Germany's biotech hotspot. In…
News
Biotech industry: Investments remain at record levels
In 2020, the first year of the coronavirus pandemic, the German biotech industry raised €3.1 billion. Last year, investments were somewhat lower,…
News
Tubulis closes Series B with 60 million euros
Tubulis secures €60 million ($63 million) in its Series B funding. The round is led by Andera Partners.…
News
Eisbach Bio receives 6.7 million euros from the Bavarian State Government
The Munich-based biotech company Eisbach Bio has received funding of 6.7 million euros for the development of antiviral agents against…
News
Munich is an outstanding biotech location in Germany
According to a recent study, 21 percent of Germany-based biotechnology companies are headquartered in the European Metropolitan Region of Munich (EMM).…
News
Nine million euros for HMNC Brain Health
HMNC Brain Health, a Munich-based biotech company specializing in the development of personalized therapies for depression and other neuropsychiatric disorders…
News
Eisbach Bio receives 8 million euros in state funding
Eisbach Bio has received funding from the German Federal Ministry of Education and Research (BMBF) for the clinical development of a COVID-19 drug…
Competition
Munich Life Science Pitch Day: Application period open
On September 30, 2021, the Innovation and Start-up Center for Biotechnology (IZB), in cooperation with High-Tech Gründerfonds and Bayer AG, will…
News
Origin.Bio secures 12 million euros
Origin.Bio, which aims to make petrochemicals obsolete with its technology, is receiving €12.3 million in investment capital. The fresh capital will…
Podcast
The Munich biotech industry under the microscope
Munich is the biotech hotspot in Germany: The city is home not only to important networks and financially strong investors, but also…
